Lisa E Hensley

Title: Innovations of Lisa E Hensley

Introduction

Lisa E Hensley is a prominent inventor based in Frederick, MD (US). She has made significant contributions to the field of vaccine development, particularly in creating multivalent vaccines that target both rabies virus and coronaviruses. With a total of seven patents to her name, her work is crucial in advancing public health.

Latest Patents

One of her latest patents focuses on multivalent vaccines for rabies virus and coronaviruses. The present disclosure provides methods and compositions for inducing an immune response that confers dual protection against infections by either or both of a rabies virus and a coronavirus. This innovation can also be used therapeutically for existing infections with rabies virus and/or a coronavirus to treat at least one symptom and to neutralize or clear the infecting agents. Specifically, the patent describes a recombinant rabies virus vector comprising a nucleotide sequence encoding at least one coronavirus immunogenic glycoprotein fragment, along with pharmaceutical compositions that include these vaccine vectors.

Career Highlights

Throughout her career, Lisa has worked with various institutions, including the University System of Maryland. Her expertise in vaccine research has positioned her as a key figure in the scientific community, contributing to advancements in immunology and infectious disease control.

Collaborations

Some of her notable coworkers include Vandana Sood and Ian MacLachlan. Their collaborative efforts have further enhanced the impact of her research and innovations in the field.

Conclusion

Lisa E Hensley's work in developing multivalent vaccines represents a significant advancement in the fight against infectious diseases. Her contributions are vital for improving public health and enhancing vaccine efficacy.